Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.850
-0.240 (-4.72%)
Mar 24, 2026, 10:25 AM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Pharmaceuticals
30.91M22.60M34.16M19.23M1.32M
Pharmaceuticals Growth
36.75%-33.83%77.63%1357.77%206.74%
Total
30.91M22.60M34.16M19.23M1.32M
Total Growth
36.75%-33.83%77.63%1357.77%206.74%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States
30.91M22.60M34.16M19.23M1.32M
United States Growth
36.75%-33.83%77.63%1357.77%206.74%
Total
30.91M22.60M34.16M19.23M1.32M
Total Growth
36.75%-33.83%77.63%1357.77%206.74%
Source: S&P Global Market Intelligence.